KRAS and familial pancreatic carcinoma: In addition to the reprogramming of glycolysis, mutant KRAS signaling contributes to phosphoglycerate kinase 1 (PGK1) translocation in mitochondrion, leading to PDHK1 phosphorylation and Oxphos restriction in pancreatic cancer cells (11).